What the biomedical community could learn from the pandemic
JOSE POZO, EUROPEAN PHOTONICS INDUSTRY CONSORTIUM
A significant problem for innovators of medical devices is how long new designs take to reach production and get into the hands of the consumers who can use them. This dilemma has become glaringly obvious as America, Europe, and the rest of the world has grappled with a disrupted supply chain during the COVID-19 pandemic.
Governmental regulation is part of the problem, requiring multiple layers of testing and approval. In both the U.S. and Europe, the groundwork must be laid to get products to clinical trial much more quickly.
But the photonics industry in the biomedical space can...Read full article
Related content from Photonics Media
Articles
Published: September 2021